Adicet Bio (Adicet Bio) Price-to-Operating-Cash-Flow

: (As of Today)

View and export this data going back to 2020. Start your Free Trial

As of today (2024-04-18), Adicet Bio's share price is $2.025. Adicet Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.18. Hence, Adicet Bio's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Adicet Bio's Price-to-Operating-Cash-Flow or its related term are showing as below:

ACET's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.36
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Adicet Bio's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $-0.54. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.18.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.60% per year.

During the past 6 years, Adicet Bio's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.30% per year. The lowest was -21.10% per year. And the median was 8.50% per year.

Adicet Bio Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Adicet Bio's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicet Bio Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Adicet Bio Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow															-	-	-	-	-

Competitive Comparison

For the Biotechnology subindustry, Adicet Bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adicet Bio Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Adicet Bio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Adicet Bio's Price-to-Operating-Cash-Flow falls into.

Adicet Bio Price-to-Operating-Cash-Flow Calculation

Adicet Bio's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	2.025	/	-2.179
	=

Adicet Bio's Share Price of today is $2.025.
Adicet Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.18.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Adicet Bio Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Adicet Bio's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicet Bio (Adicet Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adicet Bio Inc (NAS:ACET) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

1IJA:Germany 1IJA:Germany

Address

200 Clarendon Street, Floor 6, Boston, MA, USA, 02116

Website

https://www.adicetbio.com

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. The company operates and manages its business as one reportable and operating segment, which is the business of research and development of allogeneic immunotherapies for cancer and other diseases.

Executives

Chen Schor	director, officer: See Remarks	PREDIX PHARMACEUTICALS HOLDINGS, INC., 4 MAGUIRE ROAD, LEXINGTON MA 02421
Katie Peng	director	C/O ADICET BIO, INC., 200 BERKELEY STREET, 19TH FLOOR, BOSTON MA 02116
Steve Dubin	director
Orbimed Advisors Llc	director, 10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Carl L Gordon	director	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Don Healey	officer: Chief Technology Officer	2635 TECHNOLOGY FOREST BOULEVARD, THE WOODLANDS TX 77381
Blake Aftab	officer: Chief Scientific Officer	C/O ADICET BIO, INC., 200 CLARENDON STREET, FLOOR 6, BOSTON MA 02116
Francesco Galimi	officer: Chief Medical Officer	12930 VIA ESPERIA, DEL MAR CA 92014
Aya Jakobovits	director	3135 HUTTON DRIVE, BEVERLY HILLS CA 90210
Orbimed Genesis Gp Llc	director, 10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Andrew Sinclair	director	C/O SOLENO THERAPEUTICS INC., 1235 RADIO ROAD, SUITE 110, REDWOOD CITY CA 94065
Michael Kauffman	director	C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, SECOND FLOOR, NEWTON MA 02459
Bastiano Sanna	director	C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON MA 02210
Orbimed Capital Gp V Llc	director	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Carrie Krehlik	officer: Chief Human Resources Officer	6015 COLTON BLVD, OAKLAND CA 94611